GlassScriptPhysician profile
Dae B Chough
NPI 1881616134
$627.37
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $507 · 2020: $108 · 2021: $12.22.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $282.47 | 2019-2020 | |
| Medtronic Vascular, INC. | $105.13 | 2019 | |
| Janssen Pharmaceuticals, INC | $86.94 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $41.87 | 2019 | |
| Pfizer INC. | $29.08 | 2019-2020 | |
| Astellas Pharma US INC | $27.62 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.01 | 2019 | |
| Amarin Pharma, INC. | $13.68 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.55 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.02 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dae Chough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.